UBS Group’s ProMIS Neurosciences PMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-250
| Closed | -$478 | – | 8669 |
|
|
2024
Q1 | $478 | Sell |
250
-5,676
| -96% | -$10.9K | ﹤0.01% | 7355 |
|
|
2023
Q4 | $6.82K | Buy |
5,926
+5,823
| +5,653% | +$6.7K | ﹤0.01% | 6461 |
|
|
2023
Q3 | $204 | Sell |
103
-601
| -85% | -$1.19K | ﹤0.01% | 7557 |
|
|
2023
Q2 | $2.73K | Buy |
+704
| New | +$2.73K | ﹤0.01% | 6626 |
|
|
2023
Q1 | – | Sell |
-2,344
| Closed | -$10.2K | – | 8892 |
|
|
2022
Q4 | $10.2K | Sell |
2,344
-568
| -20% | -$2.47K | ﹤0.01% | 7369 |
|
|
2022
Q3 | $18K | Buy |
+2,912
| New | +$18K | ﹤0.01% | 6440 |
|